A detailed history of Edgar Lomax CO transactions in Johnson & Johnson stock. As of the latest transaction made, Edgar Lomax CO holds 204,640 shares of JNJ stock, worth $31.8 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares
204,640
Previous 207,840 1.54%
Holding current value
$31.8 Million
Previous $30.4 Million 9.17%
% of portfolio
2.04%
Previous 1.98%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $465,535 - $535,616
-3,200 Reduced 1.54%
204,640 $33.2 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $380,441 - $415,750
-2,635 Reduced 1.25%
207,840 $30.4 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $17.5 Million - $18.3 Million
112,608 Added 115.06%
210,475 $33.3 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $643,552 - $702,249
-4,420 Reduced 4.32%
97,867 $15.3 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $290,473 - $325,405
-1,865 Reduced 1.79%
102,287 $15.9 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $218,868 - $235,543
-1,418 Reduced 1.34%
104,152 $17.2 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $9.52 Million - $11.4 Million
-63,005 Reduced 37.38%
105,570 $16.4 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $152,190 - $170,800
-950 Reduced 0.56%
168,575 $29.8 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $153,263 - $170,544
-950 Reduced 0.56%
169,525 $27.7 Million
Q2 2022

Aug 10, 2022

BUY
$168.19 - $186.01 $794,697 - $878,897
4,725 Added 2.85%
170,475 $30.3 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $8.83 Million - $10 Million
-55,850 Reduced 25.2%
165,750 $29.4 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $314,978 - $349,480
-2,020 Reduced 0.9%
221,600 $37.9 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $356,107 - $395,731
-2,205 Reduced 0.98%
223,620 $36.1 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $960,866 - $1.03 Million
-6,025 Reduced 2.6%
225,825 $37.2 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $35.5 Million - $39.5 Million
231,850 New
231,850 $38.1 Million
Q1 2019

May 15, 2019

SELL
$125.72 - $139.79 $16.6 Million - $18.4 Million
-131,879 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $294,816 - $354,816
-2,400 Reduced 1.79%
131,879 $17 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $595,742 - $700,112
-4,900 Reduced 3.52%
134,279 $18.6 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $111,639 - $123,195
935 Added 0.68%
139,179 $16.9 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $3.82 Million - $4.52 Million
30,500 Added 28.31%
138,244 $17.7 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $419,904 - $459,584
-3,200 Reduced 2.88%
107,744 $15.1 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $14.4 Million - $15 Million
110,944
110,944 $14.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Edgar Lomax CO Portfolio

Follow Edgar Lomax CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.